Join to View Full Profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Dr. Leventakos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2017
- MedStar Health/Georgetown-Washington Hospital CenterResidency, Internal Medicine, 2011 - 2014
- University of Crete School of Health SciencesClass of 2005
Certifications & Licensure
- MN State Medical License 2014 - 2026
- DC State Medical License 2011 - 2012
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer Start of enrollment: 2018 Jun 15
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Combination of Lurbinectedin and Osimertinib for Treatment of-Mutated Transformed SCLC: A Brief Report.Aditi Singh, Arthi Sridhar, Aastha Poddar, Anastasios Dimou, Kaushal Parikh
JTO Clinical and Research Reports. 2025-06-01 - Clinical characteristics, outcomes, and predictive modeling of patients diagnosed with immune checkpoint inhibitor therapy-related pneumonitis.Antonious Hazim, Irene Riestra Guiance, Jacob Shreve, Gordon Ruan, Damian McGlothlin
Cancer Immunology, Immunotherapy. 2025-05-09 - JAB-3312, a Potent Allosteric SHP2 Inhibitor that Enhances the Efficacy of RTK/RAS/MAPK and PD-1 Blockade Therapies.Di Kang, Yanping Wang, Yiwei Lin, Wen Wee Ma, Daniel Morgensztern
Clinical Cancer Research. 2025-05-07
Press Mentions
- Mayo Clinic Investigator Discusses Remaining Questions on AstraZeneca’s PACIFIC Clinical Trial in Lung CancerAugust 28th, 2019
- OncLive® Presents State of the Science Summit™ on Lung CancerAugust 1st, 2019
Other Languages
- Greek
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: